Adam Shine
Stock Analyst at National Bank Financial Inc
(2.64)
# 2,006
Out of 5,117 analysts
8
Total ratings
75%
Success rate
18.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Shine
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCI Rogers Communications | Maintains: Outperform | $76 → $79 | $37.41 | +111.17% | 1 | Jun 28, 2023 | |
| BCE BCE Inc. | Maintains: Sector Perform | $63 → $62 | $23.05 | +168.98% | 5 | Jun 26, 2023 | |
| IOVA Iovance Biotherapeutics | Maintains: Equal-Weight | $14 → $11 | $2.85 | +285.96% | 1 | Mar 6, 2023 | |
| TRI Thomson Reuters | Upgrades: Outperform | n/a | $133.21 | - | 1 | Jan 11, 2022 |
Rogers Communications
Jun 28, 2023
Maintains: Outperform
Price Target: $76 → $79
Current: $37.41
Upside: +111.17%
BCE Inc.
Jun 26, 2023
Maintains: Sector Perform
Price Target: $63 → $62
Current: $23.05
Upside: +168.98%
Iovance Biotherapeutics
Mar 6, 2023
Maintains: Equal-Weight
Price Target: $14 → $11
Current: $2.85
Upside: +285.96%
Thomson Reuters
Jan 11, 2022
Upgrades: Outperform
Price Target: n/a
Current: $133.21
Upside: -